Peloton Therapeutics' Series D - II Round

Peloton Therapeutics raised a round of funding on March 14, 2017.

Peloton Therapeutics is a clinical-stage biotechnology company that discovers and develops first-in-class, small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton Ther…

Articles about Peloton Therapeutics' Series D - II Round: